Regulation of heme synthesis by mitochondrial proteins
Regulation of heme synthesis by mitochondrial proteins
批准号:
10456295
负责人:
Yvette Y Yien
金额:
$39.75万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2024-06-30
关键词:
Cell membraneCellsChildCommunitiesData SetDiseaseEnzymesErythroidErythroid CellsExclusionGeneticGoalsHemeHeme IronHomeostasisHousekeepingIron Metabolism DisordersKnowledgeLifeMetabolismMitochondriaMitochondrial ProteinsOxidation-ReductionPathway interactionsPatientsPhotosensitivityPlayPorphyriasPorphyrinsProcessProteinsProteomicsReactionRegulationResearchRespirationRoleTissuesUnderserved PopulationWomancell typecytotoxicgenome sequencinghealth managementinterestiron metabolismmutantnovelprogramsprotein complexsuccesstranscriptome sequencingunfoldasewhole genome
中文摘要
摘要
该项目的长期目标是确定调节“管家”线粒体的机制。
血红素代谢血红素在生命必需过程的氧化还原反应中起着核心作用,
线粒体呼吸我的研究项目特别感兴趣的是1。识别蛋白质
调节线粒体血红素/卟啉转运和2.这些蛋白质是
线粒体内稳态机制,在结构上或功能上与线粒体的核心酶相互作用。
血红素合成途径虽然血红素合成的酶被很好地表征,并且在所有酶中是相同的,
在组织中,将血红素合成与细胞需求相结合的调节机制非常差
明白这些调节机制的重要性由于存在着某些疾病而得到强调。
血红素合成和铁代谢是由蛋白质的失调引起的,这些蛋白质通常与
“管家”稳态过程或线粒体呼吸。尽管所有组织都需要血红素,
我们大多数关于血红素合成调控方面的研究都集中在红系细胞上,
了解血红素在其他细胞类型中的合成。这个项目使用我们的知识红血红素合成
作为一个跳板,以确定血红素监管机制所需的管家血红素合成。
项目1旨在鉴定非红细胞线粒体卟啉转运所需的蛋白质,
细胞血红素中间体是光敏的和细胞毒性的,需要细胞快速和有效地代谢血红素的机制。
有效地运输血红素中间体穿过细胞膜,到血红素合成酶中的下一个酶。
通路当不能有效转运时,细胞毒性卟啉在细胞中积累,可能导致
卟啉症和血红素缺乏症。虽然TMEM 14 C对于红系细胞中的卟啉转运是必需的,
TMEM 14蛋白不是非红系细胞中血红素合成所必需的。结合使用
TMEM 14 C抑制突变体的蛋白质组学和全基因组测序/RNAseq分析,我们将鉴定
在非红细胞中调节卟啉转运的新型线粒体蛋白。的长期目标
项目2是了解血红素合成复合物的调节蛋白质,调节管家
线粒体内稳态在这个项目期间,我们专注于普遍存在的线粒体解折叠酶,
CLPX在调节血红素合成酶的活性和蛋白质稳定性中起重要作用。
我们发现CLPX的功能是高度组织特异性的,并建议了解其在系统性
在“管家”血红素合成的环境中调节血红素代谢。这些研究将提供
重要的数据集,这将是非常宝贵的线粒体蛋白解折叠酶社区,但也将是
对于确定CLPX如何通过血红素的严格调节来全面调节线粒体稳态至关重要。
英文摘要
ABSTRACT
The long-term goal of this project is to identify the mechanisms that regulate “housekeeping” mitochondrial
heme metabolism. Heme plays a central role in the redox reactions of life-essential processes such as
mitochondrial respiration. My research program is particularly interested in 1. identifying proteins that
regulate mitochondrial heme/porphyrin transport and 2. proteins that are part of the housekeeping
mitochondrial homeostasis machinery that structurally or functionally interact with the core enzymes of the
heme synthesis pathway. While the enzymes of the heme synthesis are well characterized and identical in all
tissues, the regulatory mechanisms that couple heme synthesis to cellular requirements are very poorly
understood. The importance of these regulatory mechanisms is underscored by the existence of disorders of
heme synthesis and iron metabolism that are caused by dysregulation of proteins that are commonly associated
with “housekeeping” homeostatic processes or mitochondrial respiration. Although all tissues require heme,
most of our studies on regulatory aspects of heme synthesis have focused on erythroid cells to the exclusion of
understanding heme synthesis in other cell types. This project uses our knowledge of erythroid heme synthesis
as a springboard to identify heme regulatory mechanisms that are required for housekeeping heme synthesis.
Project 1 aims to identify proteins that are required for mitochondrial porphyrin transport in non-erythroid
cells. Heme intermediates are photosensitive and cytotoxic, requiring mechanisms for cells to quickly and
efficiently transport heme intermediates across cell membranes, to the next enzyme in the heme synthetic
pathway. When efficient transport does not occur, cytotoxic porphyrins accumulate in cells, potentially causing
porphyria and heme deficiency. While TMEM14C is essential for porphyrin transport in erythroid cells,
TMEM14 proteins are not required for heme synthesis in non-erythroid cells. Using a combination of
proteomics and whole genome sequencing/RNAseq analysis of TMEM14C suppressor mutants, we will identify
novel mitochondrial proteins that regulate porphyrin transport in non-erythroid cells. The long-term goal of
Project 2 is to understand the regulation of the heme synthesis complex by proteins that regulate housekeeping
mitochondrial homeostasis. During this project period, we focus on the ubiquitous mitochondrial unfoldase,
CLPX, which plays an essential role in regulating the activity and protein stability of heme synthesis enzymes.
We show that the function of CLPX is highly tissue-specific, and propose to understand its role in the systemic
regulation of heme metabolism in the setting of “housekeeping” heme synthesis. These studies will provide
essential datasets that will be invaluable to the mitochondrial protein unfoldase community, but will also be
essential for determining how CLPX globally regulates mitochondrial homeostasis via tight regulation of heme.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of erythroid iron metabolism by the CLPX unfoldase
-
批准号:10716494
-
项目类别:
-
资助金额:$54.25万
-
财政年份:2023
-
负责人:Yvette Y Yien
-
依托单位:
Regulation of heme synthesis by mitochondrial proteins
-
批准号:10540604
-
项目类别:
-
资助金额:$39.13万
-
财政年份:2019
-
负责人:Yvette Y Yien
-
依托单位:
Regulation of heme synthesis by mitochondrial proteins
-
批准号:10664950
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2019
-
负责人:Yvette Y Yien
-
依托单位:
Regulation of heme synthesis by mitochondrial proteins
-
批准号:10000941
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2019
-
负责人:Yvette Y Yien
-
依托单位:
Regulation of heme synthesis by mitochondrial proteins
-
批准号:10739151
-
项目类别:
-
资助金额:$7.95万
-
财政年份:2019
-
负责人:Yvette Y Yien
-
依托单位:
Mechanism and Function of TMEM14 proteins in vertebrate heme synthesis
-
批准号:9751281
-
项目类别:
-
资助金额:$15.82万
-
财政年份:2015
-
负责人:Yvette Y Yien
-
依托单位:
Regulation of mitochondrial heme metabolism by Tmem14c
-
批准号:8677578
-
项目类别:
-
资助金额:$5.6万
-
财政年份:2013
-
负责人:Yvette Y Yien
-
依托单位:
Regulation of mitochondrial heme metabolism by Tmem14c
-
批准号:8525515
-
项目类别:
-
资助金额:$5.19万
-
财政年份:2013
-
负责人:Yvette Y Yien
-
依托单位:
Project 5 Frascati-mediated Mitochondrial Metabolism, Barry Paw
-
批准号:9924635
-
项目类别:
-
资助金额:$33.9万
-
财政年份:--
-
负责人:Yvette Y Yien
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: